ASP

TSX:ASP

Acerus Pharmaceuticals Corporation

  • Stock

CAD

Last Close

0.36

26/01 15:39

Market Cap

2.77M

Beta: 1.03

Volume Today

1.25K

Avg: 1.30K

PE Ratio

−0.09

PFCF: −0.10

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
net income
-22.64M
-
-9.03M
60.12%
11.12M
223.12%
-8.71M
178.37%
-18.79M
115.58%
-16.13M
14.14%
-24.42M
51.43%
-33.82M
38.46%
depreciation and amortization
2.56M
-
2.41M
6.16%
2.21M
8.27%
2.04M
7.38%
1.95M
4.65%
1.12M
42.62%
1.01M
9.74%
681K
32.57%
deferred income tax
-411K
-
300K
172.99%
stock based compensation
703K
-
584K
16.93%
274K
53.08%
589K
114.96%
449K
23.77%
176K
60.80%
654K
271.59%
1.09M
67.43%
change in working capital
25.50M
-
-1.91M
107.51%
5.51M
387.77%
5.68M
3.12%
5.90M
3.93%
-1.28M
121.72%
-2.77M
115.99%
404K
114.59%
accounts receivables
325K
-
986K
203.38%
-357K
136.21%
106K
129.69%
inventory
2.31M
-
846K
63.44%
-191K
122.58%
641K
435.60%
248K
61.31%
720K
190.32%
-819K
213.75%
-2.29M
179.85%
accounts payables
other working capital
23.19M
-
-2.76M
111.90%
5.70M
306.49%
5.04M
11.58%
5.33M
5.77%
-2.99M
156.06%
-1.59M
46.69%
2.59M
262.59%
other non cash items
2.31M
-
7.34M
217.19%
-16.20M
320.59%
499K
103.08%
4.35M
772.34%
4.73M
8.73%
3.36M
28.97%
8.12M
141.52%
net cash provided by operating activities
8.44M
-
-1.02M
112.11%
3.21M
414.19%
99K
96.92%
-6.13M
6,292.93%
-11.38M
85.66%
-22.17M
94.74%
-23.52M
6.09%
investments in property plant and equipment
-282K
-
-779K
176.24%
-71K
90.89%
-245K
-
-113K
53.88%
-72K
-
acquisitions net
-41.41M
-
purchases of investments
sales maturities of investments
other investing activites
94K
-
97K
3.19%
10K
-
5K
-
56K
-
net cash used for investing activites
-41.60M
-
-682K
98.36%
-71K
89.59%
10K
114.08%
-245K
2,550%
-108K
55.92%
-16K
-
debt repayment
-24.65M
-
-25M
1.41%
-5.79M
76.86%
-4.10M
29.17%
-6.56M
60.18%
-79K
98.80%
-841K
964.56%
-2.53M
200.71%
common stock issued
24.87M
-
2M
-
4.38M
-
3.35M
23.45%
27.83M
730.72%
common stock repurchased
dividends paid
other financing activites
47.89M
-
5.35M
88.82%
-686K
112.82%
1.67M
342.71%
9.54M
472.85%
10.03M
5.12%
-1.53M
115.24%
19.07M
1,347.91%
net cash used provided by financing activities
48.11M
-
-19.65M
140.84%
-4.47M
77.24%
-2.43M
45.59%
7.35M
402.10%
13.30M
80.91%
25.46M
91.47%
16.54M
35.04%
effect of forex changes on cash
-2.04M
-
-3.33M
63.01%
198K
105.94%
281K
41.92%
-301K
207.12%
225K
174.75%
net change in cash
12.91M
-
-24.68M
291.26%
-1.13M
95.41%
-2.04M
80.16%
673K
132.94%
2.03M
201.78%
3.29M
62.14%
-6.99M
312.39%
cash at beginning of period
18.11M
-
31.02M
71.26%
6.33M
79.58%
5.20M
17.91%
3.16M
39.30%
3.83M
21.32%
5.86M
53.04%
9.15M
56.19%
cash at end of period
31.02M
-
6.33M
79.58%
5.20M
17.91%
3.16M
39.30%
3.83M
21.32%
5.86M
53.04%
9.15M
56.19%
2.16M
76.41%
operating cash flow
8.44M
-
-1.02M
112.11%
3.21M
414.19%
99K
96.92%
-6.13M
6,292.93%
-11.38M
85.66%
-22.17M
94.74%
-23.52M
6.09%
capital expenditure
-282K
-
-779K
176.24%
-71K
90.89%
-245K
-
-113K
53.88%
-72K
-
free cash flow
8.16M
-
-1.80M
122.08%
3.14M
274.35%
99K
96.85%
-6.38M
6,540.40%
-11.50M
80.30%
-22.17M
92.82%
-23.59M
6.41%

All numbers in CAD (except ratios and percentages)